Literature DB >> 26900306

Association between Bacterial Infection and Peripheral Vascular Disease: A Review.

Jacek Budzyński1, Joanna Wiśniewska2, Marek Ciecierski2, Anna Kędzia3.   

Abstract

There are an increasing number of data showing a clinically important association between bacterial infection and peripheral artery disease (PAD). Bacteria suspected of being involved in PAD pathogenesis are: periodontal bacteria, gut microbiota, Helicobacter pylori, and Chlamydia pneumoniae. Infectious agents may be involved in the pathogenesis of atherosclerosis via activation of a systemic or local host immunological response to contamination of extravascular tissues or the vascular wall, respectively. A systemic immunological reaction may damage vascular walls in the course of autoimmunological cross-reactions between anti-pathogen antibodies and host vascular antigens (immunological mimicry), pathogen burden mechanisms (nonspecific activation of inflammatory processes in the vascular wall), and neuroendocrine-immune cross-talk. Besides activating the inflammatory pathway, bacterial infection may trigger PAD progression or exacerbation by enhancement of platelet reactivity, by a stimulatory effect on von Willebrand factor binding, factor VIII, fibrinogen, P-selectin activation, disturbances in plasma lipids, increase in oxidative stress, and resistance to insulin. Local inflammatory host reaction and induction of atherosclerotic plaque progression and/or instability result mainly from atherosclerotic plaque colonization by microorganisms. Despite these premises, the role of bacterial infection in PAD pathogenesis should still be recognized as controversial, and randomized, controlled trials are required to evaluate the outcome of periodontal or gut bacteria modification (through diet, prebiotics, and probiotics) or eradication (using antibiotics) in hard and surrogate cardiovascular endpoints.

Entities:  

Keywords:  Helicobacter pylori; atherosclerosis; bacteria; infection; periodontitis; peripheral artery disease

Year:  2015        PMID: 26900306      PMCID: PMC4760071          DOI: 10.1055/s-0035-1547385

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  132 in total

1.  Association of Chlamydia pneumoniae and Helicobacter pylori infection with angiographically demonstrated coronary artery disease.

Authors:  Rajesh Vijayvergiya; Naveen Agarwal; Ajay Bahl; Anil Grover; Malkiat Singh; Meera Sharma; Madhu Khullar
Journal:  Int J Cardiol       Date:  2006-03-08       Impact factor: 4.164

2.  Gut microbiota: an environmental risk factor for cardiovascular disease.

Authors:  Jane Stock
Journal:  Atherosclerosis       Date:  2013-05-25       Impact factor: 5.162

3.  Detection of Helicobacter pylori in human carotid atherosclerotic plaques.

Authors:  S F Ameriso; E A Fridman; R C Leiguarda; G E Sevlever
Journal:  Stroke       Date:  2001-02       Impact factor: 7.914

4.  Acute coronary syndrome and chronic infection in the Cork coronary care case-control study.

Authors:  J Sheehan; P M Kearney; S O Sullivan; C Mongan; E Kelly; I J Perry
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

5.  Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction.

Authors:  Kunihiro Kinjo; Hiroshi Sato; Hideyuki Sato; Issei Shiotani; Toshiya Kurotobi; Yozo Ohnishi; Eiji Hishida; Daisaku Nakatani; Hiroya Mizuno; Tatsuya Sasaki; Akio Kohama; Yukichi Abe; Hisaki Morita; Mitsuaki Kubo; Hiroshi Takeda; Masatsugu Hori
Journal:  Circ J       Date:  2002-09       Impact factor: 2.993

6.  Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR.

Authors:  Abdullah Kilic; Onder Onguru; Harun Tugcu; Selim Kilic; Cakir Guney; Yasar Bilge
Journal:  Pol J Microbiol       Date:  2006

7.  Value of C-reactive protein as a risk factor for acute coronary syndrome: a comparison with apolipoprotein concentrations and lipid profile.

Authors:  Magdalena Krintus; Marek Kozinski; Anna Stefanska; Marcin Sawicki; Karolina Obonska; Tomasz Fabiszak; Jacek Kubica; Grazyna Sypniewska
Journal:  Mediators Inflamm       Date:  2012-10-16       Impact factor: 4.711

8.  Bacteremia following scaling and root planing: A clinico-microbiological study.

Authors:  Alka S Waghmare; Priyanka B Vhanmane; B Savitha; Ruhee L Chawla; Hiroj S Bagde
Journal:  J Indian Soc Periodontol       Date:  2013-11

Review 9.  Chlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysis.

Authors:  Juan Chen; Meijia Zhu; Gaoting Ma; Zhangning Zhao; Zhongwen Sun
Journal:  BMC Neurol       Date:  2013-11-21       Impact factor: 2.474

Review 10.  Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.

Authors:  Matteo Serino; Vincent Blasco-Baque; Simon Nicolas; Remy Burcelin
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

View more
  22 in total

1.  Clots retrieved by mechanical thrombectomy from acute ischemic stroke patients show no evidence of bacteria.

Authors:  Zenith Khashim; Seán Fitzgerald; Ramanathan Kadirvel; Daying Dai; Karen M Doyle; Waleed Brinjikji; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2019-04-02       Impact factor: 1.610

2.  Is the Oral Microbiome Associated with Blood Pressure in Older Women?

Authors:  Joshua H Gordon; Michael J LaMonte; Robert J Genco; Jiwei Zhao; Lu Li; Kathleen M Hovey; Maria Tsompana; Michael J Buck; Christopher A Andrews; Daniel I Mcskimming; Wei Zheng; Yijun Sun; Jean Wactawski-Wende
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-06-24

Review 3.  Peripheral artery disease: epidemiology and global perspectives.

Authors:  F Gerry R Fowkes; Victor Aboyans; Freya J I Fowkes; Mary M McDermott; Uchechukwu K A Sampson; Michael H Criqui
Journal:  Nat Rev Cardiol       Date:  2016-11-17       Impact factor: 32.419

4.  Human Oral Buccal Microbiomes Are Associated with Farmworker Status and Azinphos-Methyl Agricultural Pesticide Exposure.

Authors:  Ian B Stanaway; James C Wallace; Ali Shojaie; William C Griffith; Sungwoo Hong; Carly S Wilder; Foad H Green; Jesse Tsai; Misty Knight; Tomomi Workman; Eric M Vigoren; Jeffrey S McLean; Beti Thompson; Elaine M Faustman
Journal:  Appl Environ Microbiol       Date:  2016-12-30       Impact factor: 4.792

5.  The Global Epidemiological Transition in Cardiovascular Diseases: Unrecognised Impact of Endemic Infections on Peripheral Artery Disease.

Authors:  Paul A Agius; Julia C Cutts; Peige Song; Igor Rudan; Diana Rudan; Victor Aboyans; Mary M McDermott; Michael H Criqui; F Gerald R Fowkes; Freya J I Fowkes
Journal:  J Epidemiol Glob Health       Date:  2022-07-16

6.  Potential association between bacterial infections and ischemic stroke based on fifty case-control studies: A systematic review and meta-analysis.

Authors:  M Keikha; M Karbalaei
Journal:  New Microbes New Infect       Date:  2022-04-15

Review 7.  Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin.

Authors:  Giuseppina Pisano; Rosa Lombardi; Anna Ludovica Fracanzani
Journal:  Int J Mol Sci       Date:  2016-05-05       Impact factor: 5.923

8.  Bacterial Communities Associated with Atherosclerotic Plaques from Russian Individuals with Atherosclerosis.

Authors:  Elvira E Ziganshina; Dilyara M Sharifullina; Andrey P Lozhkin; Rustem N Khayrullin; Igor M Ignatyev; Ayrat M Ziganshin
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

9.  Lycopene Inhibits Propagation of Chlamydia Infection.

Authors:  Naylia A Zigangirova; Elena Y Morgunova; Elena D Fedina; Natalia V Shevyagina; Tatiana G Borovaya; Vladimir G Zhukhovitsky; Nigel H Kyle; Ivan M Petyaev
Journal:  Scientifica (Cairo)       Date:  2017-08-29

10.  The Porphyromonas gingivalis/Host Interactome Shows Enrichment in GWASdb Genes Related to Alzheimer's Disease, Diabetes and Cardiovascular Diseases.

Authors:  Chris J Carter; James France; StJohn Crean; Sim K Singhrao
Journal:  Front Aging Neurosci       Date:  2017-12-12       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.